divalproex sodium

Generic: divalproex sodium

Labeler: lupin pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name divalproex sodium
Generic Name divalproex sodium
Labeler lupin pharmaceuticals, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

divalproex sodium 250 mg/1

Manufacturer
Lupin Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 68180-260
Product ID 68180-260_1fc9a662-2c99-4c65-b31c-ebee40f357aa
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209286
Listing Expiration 2026-12-31
Marketing Start 2020-09-18

Pharmacologic Class

Classes
anti-epileptic agent [epc] decreased central nervous system disorganized electrical activity [pe] mood stabilizer [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68180260
Hyphenated Format 68180-260

Supplemental Identifiers

RxCUI
1099563 1099569
UPC
0368180260028
UNII
644VL95AO6

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name divalproex sodium (source: ndc)
Generic Name divalproex sodium (source: ndc)
Application Number ANDA209286 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-260-01)
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-260-02)
source: ndc

Packages (2)

68180-260-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-260-01) 68180-260-02 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-260-02)

Ingredients (1)

divalproex sodium (250 mg/1)

Linked Drug Pages (1)

Divalproex sodium ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1fc9a662-2c99-4c65-b31c-ebee40f357aa", "openfda": {"upc": ["0368180260028"], "unii": ["644VL95AO6"], "rxcui": ["1099563", "1099569"], "spl_set_id": ["1f081c74-9f73-4ed9-9157-8d73d586a409"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-260-01)", "package_ndc": "68180-260-01", "marketing_start_date": "20200918"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-260-02)", "package_ndc": "68180-260-02", "marketing_start_date": "20200918"}], "brand_name": "Divalproex sodium", "product_id": "68180-260_1fc9a662-2c99-4c65-b31c-ebee40f357aa", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "68180-260", "generic_name": "Divalproex sodium", "labeler_name": "Lupin Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "250 mg/1"}], "application_number": "ANDA209286", "marketing_category": "ANDA", "marketing_start_date": "20200918", "listing_expiration_date": "20261231"}